이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Effectiveness and Safety of Pharmacopuncture Therapy for Chronic Lumbar Radiculopathy: A Multicenter, Pragmatic, Randomized, Comparative Clinical Trial

2026년 9월 16일 업데이트: Jaseng Medical Foundation

A pragmatic clinical study to compare the effectiveness of pharmacopuncture and physical therapy strategies in patients with chronic lumbar radiculopathy

연구 개요

상세 설명

This multicenter, pragmatic, randomized, comparative clinical trial aims to evaluate the effectiveness and safety of pharmacopuncture in patients with chronic lumbar radiculopathy. A total of 92 participants with chronic lumbar radiculopathy will be recruited from four traditional Korean medicine hospitals: Recruitment will follow a competitive enrollment scheme. Participants will be randomly assigned to one of two treatment strategy groups: a pharmacopuncture group (n = 46) and a physical therapy group (n = 46). As a pragmatic trial, the specific methods of pharmacopuncture and physical therapy will not be predetermined. Instead, treatment methods will be determined by the clinical judgment of the Korean medicine doctor according to each patient's individual condition. All administered treatments will be recorded in the patients' medical records and the Case Report Form (CRF) for later comparison.

The primary objective of this study is to assess the comparative effectiveness of pharmacopuncture against physical therapy in managing chronic lumbar radiculopathy symptoms in a real-world clinical setting.

연구 유형

중재적

등록 (추정된)

92

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 장소

    • Gyeonggi-do
      • Bucheon-si, Gyeonggi-do, 대한민국
        • 완전한
        • Bucheon Jaseng Hospital of Korean Medicine
      • Seongnam-si, Gyeonggi-do, 대한민국
        • 완전한
        • Kyung Hee University Korean Medicine Hospital at Gangdong
    • Seoul
      • Seoul, Seoul, 대한민국
        • 완전한
        • Jaseng Hospital of Korean Medicine
      • Seoul, Seoul, 대한민국
        • 모병
        • Kyung Hee University Korean Medicine Hospital at Gangdong
        • 연락하다:

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

19년 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

1. Inclusion Criteria:

  1. Persistent sciatica symptoms lasting for more than 3 months.
  2. Presence of at least one of the following signs in one or both lower extremities: Muscle weakness / Dermatomal sensory disturbance (hypoesthesia, dysesthesia, tingling, or pain) / Decreased reflexes / Radiating pain aggravated by the Straight Leg Raising (SLR) test
  3. Numeric Rating Scale (NRS) score of 4 or higher for leg pain.
  4. Aged between 19 and 70 years.
  5. Provided written informed consent to participate in the clinical trial.

2. Exclusion Criteria:

  1. Diagnosed with serious conditions that may cause lower limb radiating pain (e.g., spinal metastasis of cancer, acute vertebral fracture, or dislocation).
  2. Presence of progressive neurological deficits or severe neurological symptoms.
  3. Pain originating from non-spinal soft tissue disorders (e.g., tumors, fibromyalgia, rheumatoid arthritis, gout).
  4. Presence of chronic diseases that may interfere with treatment outcomes or interpretation (e.g., stroke, myocardial infarction, renal disease, diabetic neuropathy, dementia, epilepsy).
  5. Current use of steroids, immunosuppressants, psychiatric medications, or other drugs that may affect study outcomes.
  6. Inappropriate or unsafe conditions for pharmacopuncture, including bleeding disorders, anticoagulant therapy, or severe diabetes with high infection risk.
  7. Use of analgesic medications such as Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), or receipt of acupuncture, pharmacopuncture, or physical therapy within the past 7 days.
  8. Pregnant, planning to become pregnant, or currently breastfeeding.
  9. Within 3 months post-lumbar spine surgery.
  10. Participation in another clinical trial within the past month, or planned participation in another clinical trial (including follow-up period) within 6 months from the screening date.
  11. Difficulty in completing the informed consent process.
  12. Any other condition that the investigator deems inappropriate for participation in the clinical trial.

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 하나의

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Pharmacopuncture group
  1. Acupoints:

    The selection of acupoints, needling depth, and other procedural details will be determined based on the clinical judgment of the Korean medicine doctor, taking into account the patient's symptoms, diagnostic imaging findings, and progress. All selected acupoints used for the treatment of chronic lumbar radiculopathy will be documented, and only those listed by the World Health Organization (WHO) will be used.

  2. Pharmacopuncture Solution:

The type of pharmacopuncture solution and the dosage administered will be selected at the discretion of the practitioner performing the pharmacopuncture, based on their clinical judgment. The type and total volume (in milliliters) of the pharmacopuncture solution used will be recorded for retrospective chart review. The dosage will range from 0.1 cc to 10.0 cc, depending on the clinician's decision. The selection of pharmacopuncture solutions will be limited to those already in clinical use at each participating institution.

The physicians will decide the specific methods of pharmacopuncture based on the clinical judgment according to each participant's conditions. All applied treatment methods are documented in the case report forms.

활성 비교기: Physical Therapy Group

As this is a pragmatic clinical trial, the choice of physical therapy modality, treatment area, and treatment duration will be determined based on the clinical judgment of the physician, taking into account the patient's symptoms, imaging findings, and clinical progress. All types, frequencies, and sites of physical therapy prescribed and administered will be recorded. To improve symptoms and conditions related to lumbar radiculopathy, any mechanical physical therapy modality currently used in actual clinical practice will be permitted. Examples include Interference Current Therapy (ICT) and Transcutaneous Electrical Nerve Stimulation (TENS).

The physicians will decide the specific methods of physical therapy based on the clinical judgment according to each participant's conditions. All applied treatment methods are documented in the case report forms.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Leg pain Numeric Rating Scale, NRS
기간: Week 7

Change from baseline to Week 7 on the Numeric Rating Scale of Leg pain

Week 7

2차 결과 측정

결과 측정
측정값 설명
기간
Leg and low back pain Numeric Rating Scale
기간: Week 1,2,3,4,5,6,7,13

The pain intensity of leg and low back over the past week

Week 1,2,3,4,5,6,7,13
Leg and low back pain Visual Analogue Scale
기간: Week 1,2,3,4,5,6,7

The pain intensity of leg and low back over the past week

Week 1,2,3,4,5,6,7
Oswestry Disability Index
기간: Week 1,7,13

The degree of low back disability in daily life

Week 1,7,13
Roland-Morris Disability Questionnaire
기간: Week 1,7,13

assesse the functional status of patients with low back pain

Week 1,7,13
Patient Global Impression of Change
기간: Week 7,13

The subject's subjective improvement

Week 7,13
Health-related Quality of Life Instrument with 8 Items
기간: Week 1,7,13

A tool developed to measure the health-related quality of life in Koreans

Week 1,7,13
5-Level EuroQol-5 Dimension
기간: Week 1,7,13

A tool that evaluates health status from multiple perspectives, including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression

Week 1,7,13
Adverse events
기간: Week 1,2,3,4,5,6,7,13

An undesirable and unintended sign, symptom, or disease that occurs after a procedure during the clinical study.

Week 1,2,3,4,5,6,7,13

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 연구 책임자: In-Hyuk Ha, Jaseng Medical Foundation

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2025년 8월 22일

기본 완료 (추정된)

2026년 12월 1일

연구 완료 (추정된)

2026년 12월 1일

연구 등록 날짜

최초 제출

2025년 7월 15일

QC 기준을 충족하는 최초 제출

2026년 9월 16일

처음 게시됨 (실제)

2026년 9월 21일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 9월 21일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 9월 16일

마지막으로 확인됨

2026년 9월 1일

추가 정보

이 연구와 관련된 용어

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다